India at an IP Crossroads

Image: ©iStockphoto.com / N Vasuki Rao

Once as shining example for economic opportunity, local policymakers and the judiciary have puzzlingly set India on a course that has left the innovative industries unsettled. Earlier this week, the GIPC joined Former U.S. Trade Representative Charlene Barshefsky, Information Technology & Innovation Foundation’s (ITIF) Senior Analyst Stephen Ezell, and Third Way’s Senior Fellow for Trade Ed Gerwin in an event to discuss the ramifications of India’s rapidly deteriorating intellectual property (IP) environment.

Tags: Compulsory licensing, Economy, Ed Gerwin, India, innovation, ITIF, Prtibha Patil, Stephen Ezell, The Economist, Third Way

U.S. Chamber Comments on Special 301 Report

The U.S. Chamber of Commerce today urged foreign governments to improve their intellectual property (IP) enforcement efforts, following the Office of the U.S. Trade Representative’s (USTR) release of its annual Special 301 Report.

Tags: Canada, India, International, Measuring Momentum, Special 301, Ukraine, USTR

State of Intellectual Property

As we celebrate World IP Day, it is worthwhile to review advancements made over the past year and the current “state of intellectual property.” The theme of World IP Day this year, Creativity: The Next Generation, puts into perspective how creativity and innovation will lead the next generation into the future. But how is that creativity and intellectual property being treated in 2013?

Tags: ASOP, biologics, Canada, China, Copyright Alert System, Enforcement, ICE, India, Internet, IPEC, Measuring Momentum, patent, plain packaging, Russia, Special 301, State of IP, TPP, Ukraine, USTR

India’s Dangerous Precedent

12.7 million people were diagnosed with cancer in 2008, and that number is expected to rise to 22.2 million by 2030. The imperative to find a cure for cancer and other devastating diseases couldn’t be clearer. But the path forward was muddied by India’s Supreme Court decision this week.

Tags: Glivec, India, innovation, Novartis, patent

U.S. Chamber’s Global Intellectual Property Center Comments on Indian Supreme Court Patent Ruling

Decision Undermines Intellectual Property Rights, Casts Doubt on Future Innovation and Investment

Tags: Glivec, India, Mark Elliot, Measuring Momentum, Novartis, patent

Tag Archives: India

India at an IP Crossroads